Moreover, previous studies provided evidence on aging as a potential factor that affects responses to SOD mimetics, as the SOD mimetic AVA was shown to exert protective effects in normal tissues in fibroblasts from older patients against chemoradiation, older mice against cisplatin-induced renal injury, and in older patients with cisplatin-induced acute kidney injury [178,183]. Here, SOD1 is linked to acute kidney injury.